Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C7H14N2O3 |
| Molecular Weight | 174.1977 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC(=O)CC[C@H](N)C(O)=O
InChI
InChIKey=DATAGRPVKZEWHA-YFKPBYRVSA-N
InChI=1S/C7H14N2O3/c1-2-9-6(10)4-3-5(8)7(11)12/h5H,2-4,8H2,1H3,(H,9,10)(H,11,12)/t5-/m0/s1
| Molecular Formula | C7H14N2O3 |
| Molecular Weight | 174.1977 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
L-Theanine is a relaxing and nondietary amino acid found pretty much exclusively in teas from Camellia sinensis (alongside green tea catechins and caffeine) and is known to promote relaxation without sedation. It appears to be effective at this as well as reducing stress at standard dosages. L-theanine was discovered as a constituent of green tea in 1949 and was approved in Japan in 1964 for unlimited use in all foods, including chocolates, soft drinks, and herb teas, except infant foods. It also provides a unique umami (brothy or savory) taste and flavor to green tea infusion. L-theanine may help relieve stress by inducing a relaxing effect without drowsiness and may also possess immunologic attributes. Theanine may also have effects on the cardiovascular system and play a preventative role in cancer; however, limited clinical information is available to support these claims. L-Theanine and its positive effects on cognitive performance is one of its most important
functions. Because of chemical structure of L-Theanine similar to glutamate it can act as a neurotransmitter
related to memory. In a study made on rats, it was found out that L-Theanine
modulated the serotonin and dopamine levels and increased learning skills with memory. In addition, it is stated that L-Theanine increases neuro - throphine mRNA level by
activating its neuro - transmitter inhibiting system and supports the central nervous system that
helps the development of brain functions. L-Theanine had a positive effect on memory
and had positive effects on the treatment and prevention of Alzheimer. Theanine is an antagonist of the NMDA receptors (albeit with fairly weak efficacy) and can inhibit synaptic release of glutamate via blocking the transporter competitively. Theanine may also reduce glutamate levels, but this is also a fairly weak mechanism requiring a high concentration of theanine.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26192072 | https://examine.com/supplements/theanine/
Curator's Comment: Orally administered L-Theanine supplementation is able to cross the blood brain barier.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL230 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24762604 |
|||
Target ID: CHEMBL2096670 |
24.6 µM [IC50] | ||
Target ID: CHEMBL2109241 |
41.5 µM [IC50] | ||
Target ID: CHEMBL2094124 |
347.0 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | ZEN THEANINE Approved UseZEN THEANINE is used to provide fast-acting mental relaxation, with its stress reducing effects typically felt within 30 minutes of consumption. |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
24.3 μM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
THEANINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
2.8 μM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
THEANINE red blood cells | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
43.1 μM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUTAMIC ACID red blood cells | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
12.9 μM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUTAMIC ACID plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
6.1 μM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
ETHYLAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
57.1 μM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
THEANINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
50.5 μM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
THEANINE red blood cells | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
276 μM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUTAMIC ACID red blood cells | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
38.9 μM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
GLUTAMIC ACID plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
|
101 μM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
ETHYLAMINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1.2 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23096008/ |
100 mg single, oral dose: 100 mg route of administration: Oral experiment type: SINGLE co-administered: |
THEANINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
PubMed
| Title | Date | PubMed |
|---|---|---|
| l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. | 2009-12-01 |
|
| The effect of taurine, a novel biochemical modulator, on the antitumor activity of doxorubicin. | 2009-09 |
|
| Ethylamine content and theanine biosynthesis in different organs of Camellia sinensis seedlings. | 2009-08-15 |
|
| Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma. | 2009-08 |
|
| Bioactive components of tea: cancer, inflammation and behavior. | 2009-08 |
|
| Impact of two types of Internet-based information on medical students' performance in an Objective Structured Clinical Exam (OSCE). | 2009-07 |
|
| Changes in the composition of raw tea leaves from the Korean Yabukida plant during high-temperature processing to pan-fried Kamairi-cha green tea. | 2009-06 |
|
| The effects of L-theanine on alpha-band oscillatory brain activity during a visuo-spatial attention task. | 2009-06 |
|
| Effects of oral supplementation with cystine and theanine on the immune function of athletes in endurance exercise: randomized, double-blind, placebo-controlled trial. | 2009-04-23 |
|
| Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells. | 2009-04 |
|
| Rat electropharmacograms of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or neuroprotective action. | 2009-04 |
|
| Tea and health: preventive and therapeutic usefulness in the elderly? | 2009-01 |
|
| Theanine, gamma-glutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats. | 2009-01 |
|
| Aqueous fish extract increases survival in the mouse model of cytostatic toxicity. | 2008-12-04 |
|
| Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity. | 2008-12 |
|
| L-theanine elicits an umami taste with inosine 5'-monophosphate. | 2008-11 |
|
| Determination of theanine, GABA, and other amino acids in green, oolong, black, and Pu-erh teas with dabsylation and high-performance liquid chromatography. | 2008-09-10 |
|
| [Determination of hydroxyproline in collagenous proteins by high performance liquid chromatography-mass spectrometry]. | 2008-09 |
|
| [The effect of theanine on oxygen-induced retinal neovascularization in the neonatal rat]. | 2008-08 |
|
| The combined effects of L-theanine and caffeine on cognitive performance and mood. | 2008-08 |
|
| Immobilization of Escherichia coli novablue gamma-glutamyltranspeptidase in Ca-alginate-kappa-carrageenan beads. | 2008-08 |
|
| Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. | 2008-07 |
|
| Theanine, an ingredient of green tea, inhibits [3H]glutamine transport in neurons and astroglia in rat brain. | 2008-06 |
|
| Theanine production by coupled fermentation with energy transfer using gamma-glutamylmethylamide synthetase of Methylovorus mays No. 9. | 2008-05 |
|
| Administration of theanine, a unique amino acid in tea leaves, changed feeding-relating components in serum and feeding behavior in rats. | 2008-05 |
|
| Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioral test. | 2008-05 |
|
| Altered levels of oxidation and phospholipase C isozyme expression in the brains of theanine-administered rats. | 2008-05 |
|
| Effect of green tea and (-)-epigallocatechin gallate on ethanol-induced toxicity in HepG2 cells. | 2008-05 |
|
| L-theanine intervention enhances human gammadeltaT lymphocyte function. | 2008-02 |
|
| Psychological effects of dietary components of tea: caffeine and L-theanine. | 2008-02 |
|
| The effects of L-theanine, caffeine and their combination on cognition and mood. | 2008-02 |
|
| Cloning and expression of Methylovorus mays No. 9 gene encoding gamma-glutamylmethylamide synthetase: an enzyme usable in theanine formation by coupling with the alcoholic fermentation system of baker's yeast. | 2008-01 |
|
| Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. | 2008-01 |
|
| Theanine prevents memory impairment induced by repeated cerebral ischemia in rats. | 2008-01 |
|
| L-theanine, a natural constituent in tea, and its effect on mental state. | 2008 |
|
| Enhancement of antigen-specific immunoglobulin G production in mice by co-administration of L-cystine and L-theanine. | 2007-12 |
|
| Source density analysis of the human EEG after ingestion of a drink containing decaffeinated extract of green tea enriched with L-theanine and theogallin. | 2007-11-21 |
|
| A soothing sip of focus. The latest on tea: it might quiet distracted minds. | 2007-10-08 |
|
| [Effects of theanine and houpu extract in 7-day chick social separation-stress procedure]. | 2007-10 |
|
| Involvement of GABA(A) receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice. | 2007-10 |
|
| Theogallin and L-theanine as active ingredients in decaffeinated green tea extract: II. Characterization in the freely moving rat by means of quantitative field potential analysis. | 2007-10 |
|
| Theanine, r-glutamylethylamide, increases neurotransmission concentrations and neurotrophin mRNA levels in the brain during lactation. | 2007-09-29 |
|
| Determination of amino acids in tea leaves and beverages using capillary electrophoresis with light-emitting diode-induced fluorescence detection. | 2007-09-15 |
|
| [Separation and quantification of theanine enantiomers using high performance liquid chromatography coupled with chiral derivatization]. | 2007-09 |
|
| Theogallin and L-theanine as active ingredients in decaffeinated green tea extract: I. electrophysiological characterization in the rat hippocampus in-vitro. | 2007-08 |
|
| Differentiation of green, white, black, Oolong, and Pu-erh teas according to their free amino acids content. | 2007-07-25 |
|
| Effects of green tea fractions on oxygen-induced retinal neovascularization in the neonatal rat. | 2007-07 |
|
| [Determination of amino acids in tea samples by capillary electrophoresis with partition cell and indirect ultraviolet detection]. | 2007-03 |
|
| Spontaneous renal tubular hyperplastic and neoplastic lesions in three Sprague-Dawley rats from a 90-day toxicity study. | 2007-02 |
|
| Inhibitory effects of theanine and sera from theanine-fed rats on receptor-mediated cancer cell invasion beneath mesothelial-cell monolayers. | 2001-07 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/npc/l-theanine.html
Studies reporting an anti-anxiety effect used single doses of theanine 200 to 250 mg.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24762604
Theanine promoted DC secretion of IL-12. IL-12 levels reached (137.4 ± 4.9) pg/ml with theanine at 200 umol/L. However, theanine inhibited the secretion of IL-10 in a dose-dependent manner. IL-10 levels were only (58.4 ± 6.9) pg/ml with theanine at 200 umol/L.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:00 GMT 2025
by
admin
on
Mon Mar 31 18:22:00 GMT 2025
|
| Record UNII |
8021PR16QO
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
607 (Number of products:983)
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
221-379-0
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
100000126208
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
338
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
21308
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
C026166
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
C87348
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
DTXSID80184817
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
38022
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | RxNorm | ||
|
17394
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
C1505
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
CONCEPT | Dietary Supplement | ||
|
1652704
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
THEANINE
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
SUB33407
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
m10694
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | Merck Index | ||
|
8021PR16QO
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
209
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
8166
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
SUB33692
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
8021PR16QO
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
439378
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
58128
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
501
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
3081-61-6
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY | |||
|
DB12444
Created by
admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |